Concealment of Parkinson’s Disease: Prevalence and Impact on Health and Quality of Life
Objective: (1) To explore the proportion and personal characteristics of patients who do not disclose their diagnosis of Parkinson's disease (PD) to their family, and…Effectiveness of speech therapy in patients with Parkinson’s disease – a randomized controlled trial
Objective: We aimed to assess the effectiveness of speech therapy on improving quality of life and speech quality in patients with Parkinson’s disease. Background: Although…Structural MRI and tremor analysis in the differential diagnosis of rest tremor
Objective: This study aimed to differentiate between essential tremor with rest tremor (rET) and tremor-dominant Parkinson’s disease (td-PD) patients through a machine learning (ML) approach…A Novel Real Time Algorithm to Predict Freezing of Gait in Parkinson’s Patients Using Wearable Mobility Sensors Data
Objective: To develop an algorithm for real-time Freezing of gait (FOG) prediction based on the online monitoring of the stepping coherence. Background: FOG is a…Role of ATP10B variants in Parkinson Disease in a southern Spanish cohort
Objective: The objective of our study was to evaluate the role of ATP10B variants in Parkinson disease (PD) in a southern Spanish cohort of PD…Cerebrospinal fluid biomarkers for diagnosis of Parkinson’s disease: a systematic review and network meta-analysis
Objective: In this study, we intended to use network meta-analysis to compare the diagnostic performances of different CSF biomarkers in the diagnosis and differential diagnosis…Salivary α-synuclein in Parkinson’s disease – a pilot study
Objective: The aim of our study was to measure total salivary α-synuclein in Parkinson´s disease (PD) patients to assess its potential as a biomarker of…Physical exercise as a promising option for treating fatigue in Parkinson’s disease? Results of a systematic review and meta-analysis of non-pharmacological interventions
Objective: To give an update on randomized controlled trials (RCT) including non-pharmacological intervention approaches that examine effects on fatigue in people with Parkinson’s disease (PD).…Using mediation analysis to account for the effect of Parkinson’s Disease medications on disease progression
Objective: To explore the use of mediation analysis to incorporate L-dopa equivalent daily dose (LEDD) for disease progression of Parkinson’s Disease (PD) in a simulation…Open-label Extension Study of Long-term Safety and Tolerability of Foslevodopa/Foscarbidopa for Treatment of Advanced Parkinson’s Disease
Objective: To evaluate long-term safety/tolerability of foslevodopa/foscarbidopa (LDP/CDP) in patients with advanced Parkinson’s disease (aPD) in a phase 3 open-label extension (OLE) study. Background: LDP/CDP…
- « Previous Page
- 1
- …
- 123
- 124
- 125
- 126
- 127
- …
- 338
- Next Page »